The UK's drug cost-effectiveness watchdog has recommended Alnylam Pharmaceuticals' heart disease drug, ensuring access for ...

Akeso has a validated process in place for developing antibodies but does require US exposure to meet its lofty valuation.

Pfizer and Tris Pharma agreed to a $41.5 million settlement with Texas over claims they manipulated quality-control testing ...

Texas Attorney General Paxton secures a $41.5 million settlement with Pfizer and Tris Pharma over allegations of providing ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Healthcare giant Pfizer ( PFE 2.24%) has been offering a high yield for some time. But that hasn't been enough to get ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Tech strength drives the Nasdaq. Semis pop. A major consumer deal hits the tape. EV sales cool. Earnings on deck include ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

Activist investor Starboard Value has liquidated its position in Pfizer , according to a regulatory filing on Friday, ending ...